Growth Metrics

Gilead Sciences (GILD) Net Cash Flow (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -67.25%
Dec 31, 2025 -89.55%
Sep 30, 2025 176.75%
Jun 30, 2025 -37.04%
Mar 31, 2025 -141.60%
Dec 31, 2024 125.68%
Sep 30, 2024 214.73%
Jun 30, 2024 -43.44%
Mar 31, 2024 -493.29%
Dec 31, 2023 4,800.00%
Sep 30, 2023 -99.07%
Jun 30, 2023 254.51%
Mar 31, 2023 -176.49%
Dec 31, 2022 1,893.75%
Sep 30, 2022 -93.48%
Jun 30, 2022 147.95%
Mar 31, 2022 -203.96%
Dec 31, 2021 293.90%
Sep 30, 2021 -162.87%
Jun 30, 2021 142.33%
Mar 31, 2021 72.45%
Dec 31, 2020 -213.55%
Sep 30, 2020 283.22%
Jun 30, 2020 -119.29%
Mar 31, 2020 -171.82%
Dec 31, 2019 223.61%
Sep 30, 2019 69.87%
Jun 30, 2019 -449.66%
Mar 31, 2019 -130.29%
Dec 31, 2018 155.24%
Sep 30, 2018 -76.40%
Jun 30, 2018 19,424.14%
Mar 31, 2018 100.74%
Dec 31, 2017 -242.40%
Sep 30, 2017 271.88%
Jun 30, 2017 -180.48%
Mar 31, 2017 233.96%
Dec 31, 2016 -145.34%
Sep 30, 2016 2,237.86%
Jun 30, 2016 102.12%
Mar 31, 2016 -494.95%
Dec 31, 2015 -116.91%
Sep 30, 2015 302.60%
Jun 30, 2015 -575.74%
Mar 31, 2015 -82.34%
Dec 31, 2014 254.12%
Sep 30, 2014 -207.35%
Jun 30, 2014 -45.77%
Mar 31, 2014 4,258.73%
Dec 31, 2013 149.93%
Sep 30, 2013 -158.01%
Jun 30, 2013 416.19%
Mar 31, 2013 -73.23%
Dec 31, 2012 406.70%
Sep 30, 2012 -144.35%
Jun 30, 2012 102.14%
Mar 31, 2012 -194.29%
Dec 31, 2011 15,155.73%
Sep 30, 2011 93.39%
Jun 30, 2011 -189.38%
Mar 31, 2011 804.82%
Dec 31, 2010 62.88%
Sep 30, 2010 -182.37%
Jun 30, 2010 222.07%
Mar 31, 2010 -263.66%
Dec 31, 2009 2,628.91%
Sep 30, 2009 101.43%
Jun 30, 2009 -456.79%